Abstract
Cancer is a world-famous deadly disease. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. One well-known technique for cancer detection is the DNA microarray technique. DNA microarray technology provides an opportunity for researchers to analyze thousands of gene expression profiles at the same time to determine whether a person has cancer or not. However, one of the problems in DNA microarray data is the large number of features that require feature selection. In overcoming these problems, this study will use the feature selection Support Vector Machine-Recursive Feature Elimination (SVM-RFE) and Chi-Square and use the Naive Bayes classification method. The accuracy results from using feature selection with those that are not will be compared. The accuracy between using the two feature selection methods will also be compared to find which feature selection method is better when combined with the Naive Bayes classification method. To get an overall picture of the performance comparison, this study also considers precision, recall, and F1-score. The best accuracy results obtained were 100% lung cancer data with SVM-RFE and Chi-Square, 99.6% ovarian cancer with SVM-RFE, 93.7% breast cancer with SVM-RFE, and 90% colon cancer with SVM- RFE.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.